Transthyretin-derived senile systemic amyloidosis: Clinicopathologic and structural considerations

Amyloid

Volumn 10, Issue SUPPL. 1, 2003, Pages 48-54

  Westermark, Per ^a   Bergström, Joakim ^a   Solomon, Alan ^b   Murphy, Charles ^b   Sletten, Knut ^c  

^a UPPSALA UNIVERSITY   (Sweden)

^b UNIVERSITY OF TENNESSEE GRADUATE SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF OSLO   (Norway)

Author keywords

Amyloid; Fibril; Heart; Kidney; Lung; Transthyretin

Indexed keywords

PREALBUMIN; PROTEIN PRECURSOR;

AGED; AGING; AMYLOIDOSIS; AUTOPSY; CARBOXY TERMINAL SEQUENCE; CLINICAL ARTICLE; CONFERENCE PAPER; EPITOPE MAPPING; FEMALE; GENE MUTATION; GENETIC VARIABILITY; HISTOPATHOLOGY; HUMAN; KIDNEY FUNCTION; MALE; PERIPHERAL NERVE; PRIORITY JOURNAL; SYSTEMIC DISEASE;

EID: 0242391991     PISSN: 13506129     EISSN: None     Source Type: Journal    
DOI: 10.1080/13506129.2003.12088568     Document Type: Conference Paper

References (35)

1. Sletten K, Westermark P and Natvig JB (1980). Senile cardiac amyloid is related to prealbumin. Scand J Immunol 12, 503-506
2. Westermark P, Sletten K, Johansson B, Cornwell GG, III (1990). Fibril in senile systemic amyloidosis is derived from normal transthyretin. Proc Natl Acad Sci USA 87, 2843-2845
3. Cornwell GG, III, Murdoch WL, Kyle RA, Westermark P and Pitknen P (1983). Frequency and distribution of senile cardiovascular amyloid. Am J Med 75, 618-623
4. Westermark P, Johansson B and Natvig JB (1979). Senile cardiac amyloidosis: evidence of two different amyloid substances in the ageing heart. Scand J Immunol 10, 303-308
5. Eneqvist T and Sauer-Eriksson AE (2001). Structural distribution of mutations associated with familial amyloidotic polyneuropathy in human transthyretin. Amyloid: J Protein Folding Disord 8, 149-168
6. Hamilton JA and Benson MD (2001). Transthyretin: a review from a structural perspective. Cell Mol Life Sci 58, 1491-1521
7. Lai Z, Coln W and Kelly JW (1996). The acid-mediated denaturation pathway of transthyretin yields a conformational intermediate that can self-assemble into amyloid. Biochemistry 35, 6470-6482
8. Westermark P, Sletten K and Olofsson B-O (1987). Prealbumin variants in the amyloid fibrils of Swedish familial amyloidotic polyneuropathy. Clin Exp Immunol 69 695-701
9. Benson MD (1989). Familial amyloidotic polyneuropathy. Trends Biochem Sci 12, 88-92
10. Yazaki M, Tokuda T, Nakamura A, Higashikata T, Koyama J, Higuchi K, Harihara Y, Baba S, Kametani F and Ikeda S (2000). Cardiac amyloid in patients with familial amyloid polyneuropathy consists of abundant wild-type transthyretin. Biochem Biophys Res Commun 274, 702-706
11. Gustavsson, Jahr H, Tobiassen R, Jacobson DR, Sletten K, Westermark P (1995). Amyloid fibril composition and transthyretin gene structure in senile systemic amyloidosis. Lab Invest 73, 703-708
12. Christmanson L, Betsholtz C, Gustavsson, Johansson B, Sletten K and Westermark P (1991). The transthyretin cDNA sequence is normal in transthyretin-derived senile systemic amyloidosis. FEBS Lett 281, 177-180
13. Gustavsson, Engstrm U and Westermark P (1994). Mechanisms of transthyretin (TTR) amyloidogenesis: antigenie mapping of transthyretin purified from plasma and amyloid fibrils and within in situ tissue localizations. Am J Pathol 144, 1301-1311
14. Kaplan B, Hrncic R, Murphy CL, Gallo G, Weiss DT and Solomon A (1999). Microextraction and purification techniques applicable to chemical characterization of amyloid proteins in minute amounts in tissue. Meth Enzymol 309, 67-81
15. Bergstrm J, Murphy C, Eulitz M, Weiss DT, Westermark GT, Solomon A and Westermark P (2001). Codeposition of apolipoprotein A-IV and transthyretin in senile systemic (ATTR) amyloidosis. Biochem Biophys Res Commun 285, 903-908
16. Gustavsson, Engstrm U, Westermark P (1997). Transthyretin (TTR-) derived amyloid fibrils: immunoelectron microscopy of fibrils formed in vivo and in vitro from synthetic peptides and normal transthyretin. Amyloid: Int J Exp Clin Invest 4, 1-12
17. Johansson B, Wernstedt C and Westermark P (1987). Atrial natriuretic peptide deposited as atrial amyloid fibrils. Biochem Biophys Res Commun 148, 1087-1092
18. Pomerance A, Slavin G and McWatt J (1976). Experience with the sodium sulphate-Alcian Blue stain for amyloid in cardiac pathology. J Clin Pathol 29, 22-26
19. Wright JR and Calkins E (1981). Clinical-pathologic differentiation of common amyloid syndromes. Medicine 60, 429-448
20. Jacobson DR, Pastore RD, Yaghoubian R, Kane I, Gallo G, Buck FS and Buxbaum JN (1997). Variant-sequence transthyretin (isoleucine 122) in late-onset cardiac amyloidosis in black Americans. N Engl J Med 336, 466-473
21. Frederiksen T, Gotzsche H, Harboe N, Klaer W and Mellengaard K (1962). Familial primary amyloidosis with severe amyloid heart disease. Am J Med 33, 328-348
22. Nordlie M, Sletten K, Husby G and Ranl¿v P (1988). A new prealbumin variant in familial amyloid cardiomyopathy of Danish origin. Scand J Immunol 27, 119-122
23. Kyle RA, Spittell PC, Gertz MA, Li C-Y, Edwards WD, Olson LJ and Thibodeau SN (1996). The premortem recognition of systemic senile amyloidosis with cardiac involvement. Am J Med 171, 395-400
24. Olsen KE, Sletten K and Westermark P (1998). Extended analysis of AL-amyloid protein from abdominal wall subcutaneous fat biopsy: kappa IV immunoglobulin light chain. Biochem Biophys Res Commun 245, 713-716
25. Pitknen P, Westermark P and Cornwell GG III (1984). Senile systemic amyloidosis. Am J Pathol 117, 391-399
26. Johansson B and Westermark (1991). Senile systemic amyloidosis: a clinico-pathological study of twelve patients with massive amyloid infiltration. Int J Cardiol 32, 83-92
27. Ridolfi RL, Bulkley BH and Hutchins GM (1977). The conduction system in cardiac amyloidosis. Clinical and pathological features of 23 patients. Am J Med 62, 677-686
28. Takahashi K, Yi S, Kimura Y and Araki S (1991). Familial amyloidotic polyneuropathy type 1 in Kumamoto, Japan. A clinicopathologic, histochemical, immunohistochemical, and ultrastructural study. Hum Pathol 22, 519-527
29. Westermark P, Pitknen P, Benson L, Vahlquist A, Olofsson B-O and Cornwell GG III (1985). Serum prealbumin and retinol-binding protein in the prealbumin-related senile and familial forms of systemic amyloidosis. Lab Invest 52, 314-318
30. Benson MD and Dwulet FE (1983). Prealbumin and retinol binding protein serum concentrations in the Indiana type hereditary amyloidosis. Arthritis Rheum 26, 1493-1498
31. Olofsson B-O, Backman C, Karp K and Suhr OB (2002). Progression of cardiomyopathy after liver transplantation in patients with familial amyloidotic polyneuropathy, Portuguese type. Transplantation 5, 745-751
32. Felding P, Fex G, Westermark P, Olofsson B-O, Pitknen P and Benson L (1985). Prealbumin in Swedish patients with senile systemic amyloidosis and familial amyloidotic polyneuropathy. Scand J Immunol 21, 133-140
33. Liu K, Cho HS, Lashuel HA, Kelly JW and Wemmer DE (2000). A glimpse of a possible amyloidogenic intermediate of transthyretin. Nature Struct Biol 7, 754-757
34. Thyln C, Wahlqvist J, Haettner E, Sandgren O, Holmgren G and Lundgren E (1993). Modifications of transthyretin in amyloid fibrils: analysis of amyloid from homozygous and heterozygous individuals with the Met30 mutation. Embo J 12, 743-748
35. Teng MH, Yin JY, Vidal R, Ghiso J, Kumar A, Rabenou R, Shah A, Jacobson DR, Tagoe C, Gallo G and Buxbaum J (2001). Amyloid and nonfibrillar deposits in mice transgenic for wild-type human transthyretin: a possible model for senile systemic amyloidosis. Lab Invest 81, 385-396